Selective prophylactic anti-tuberculosis strategy is superior for Chinese patients with inflammatory bowel disease receiving infliximab treatment: a multi-centre retrospective study-MedSci.cn

Selective prophylactic anti-tuberculosis strategy is superior for Chinese patients with inflammatory bowel disease receiving infliximab treatment: a multi-centre retrospective study

Ye, L; Chen, M; Gao, X; Wu, K; Ran, Z; Yang, H; Liu, Z; Cao, Q

JOURNAL OF CROHNS & COLITIS, 2019; 13 (): S353

科室
- - 订阅+
  - 更多科室
工具
服务